Evaluation of vascularization of coralline hydroxyapatite ocular implants by magnetic resonance imaging

      This paper is only available as a PDF. To read, Please Download here.


      A coralline hydroxyapatite orbital implant may be placed after ocular enucleation or evisceration. It must be vascularized to support epithelialization of a hole drilled in its anterior face for insertion of a motility peg. We used gadolinium-DTPA enhanced magnetic resonance imaging (MRI) of the orbits of two patients to assess fibrovascular penetration into their implants. MRI provides a reliable determination of implant vascularization and greater anatomic detail than 99m technetium-MDP bone scanning.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Perry A.C.
        Advances in enucleation.
        Ophthalmol Clin N Am. 1991; 4: 173-182
        • Perry A.C.
        When to drill the biomatrix hydroxyapatite ocular implant.
        Journal of the American Society of Ocularists. 1991; : 5-7
        • Dutton J.J.
        Coralline hydroxyapatite as an ocular implant.
        Ophthalmology. 1991; 98: 370-377
        • Mules P.H.
        Evisceration of the globe, with artificial vitreous.
        Trans Ophthalmol Soc UK. 1885; 5: 200-206
        • Frost W.A.
        What is the best method of dealing with a lost eye?.
        BMJ. 1887; 1: 1153-1154
        • Ruedeman A.D.
        Plastic eye implant.
        Am J Ophthalmol. 1946; 29: 947-952
        • Gougelmann H.P.
        The evolution of the ocular motility implant.
        Int Ophthalmol Clin. 1976; 10: 689-711
        • Joslin C.
        Inside R & D's monthly report on technology transfer.
        Inside R & D. 1984; 13: 3
        • Shields C.L.
        • Shields J.A.
        • Eagle R.C.
        • De Potter P.
        Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.
        Am J Ophthalmol. 1991; 111: 363-366